VRESKEZ
LIVE

Serial Number

79385524

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Nov 10, 2023

Add to watchlist:

No watchlists yet
View on USPTO

VRESKEZ Trademark

Serial Number: 79385524 • Registration: 7459375

VRESKEZ is a trademark filed by NOVARTIS AG on November 10, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

November 10, 2023

Registration Date

July 30, 2024

Published for Opposition

May 14, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 12, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 13, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 13, 2025 OPNR
NOTIFICATION PROCESSED BY IB
Feb 21, 2025 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jan 29, 2025 FICS
FINAL DISPOSITION PROCESSED
Jan 29, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 31, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 30, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 30, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 14, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 14, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 5, 2024 CNSA
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Feb 13, 2024 RFWR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 5, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 5, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 5, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 5, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 5, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 5, 2024 COAR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 25, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jan 24, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 18, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 19, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 15, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 15, 2023 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Dec 14, 2023 SDRC